DIDAK INJECTION
ActiveFrom the official registers: KBO 40 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
DIDAK INJECTION has been active since 1986 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €14.4m and a net result of €2.3m. Equity has been stable since 2018 (±1.3% per year). Its solvency ranks better than 57% of 230 sector peers (NACE 22, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Official details
KBO- Status
- Active since 02-01-1986 Normal situation
- Activity
- Manufacture of rubber and plastic products NACE 22260and 1 other
- Establishment unit
- 2.028.517.250 2280 Grobbendonk, since 01-01-1986
- Financial year end
- 31 December
- Peppol
- Reachable since 05-01-2026
Board and ownership
- VERBIST PeterDaily manager
- ECNOELDirector · permanent representative DECEUNINCK Alexander
- VANDEPUTTE-VALCKEDirector · permanent representative VANDEPUTTE Peter
- VALTECHDirector · permanent representative Frank Vandeputte
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.2%
- Turnover
- €43.5m
- ▲ 11.0%
- Profit
- €2.3m
- ▲ 7.5%
- Equity
- €14.4m
- ▲ 8.3%
- Total assets
- €25.3m
- ▲ 1.1%
- Staff
- 80.6 FTE
- ▼ 7.4%
Score breakdownraises riskLiquidity: current ratio 1.22, cash €226,769, halvedlowers riskFounded in 1986Equity €14.4m (57.0% of total assets)Profit of €2.3m (financial year 2025)Show the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 22, medium-sized). It does better than 58% of them on solvency, 28% on liquidity, 74% on profitability and 77% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 4 days after the deadline. In the sector (NACE 22), the median for financial year 2024 was 14 days before the deadline, and 34% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: 5th largest company by equity in Grobbendonk, Manufacturing sectorin the Checked rankings No. 5 View
- Positive: 8 profitable years in a rowprofit 2025: €2.3m 8 years View
- Board changedlatest change 16-07-2026 · 3 in office 1 joined · 1 left View
- Flemish supportawarded from 2022 to 2025 €252,223 View
Comparable companies
These companies have the same main activity as DIDAK INJECTION: manufacture of rubber and plastic products (NACE 22260). They are comparable in size and age: total assets between €11m and €37m, founded between 1970 and 1997.
| Company | Total assets | Turnover |
|---|---|---|
| DIDAK INJECTION Grobbendonk | €25.3m | €43.5m |
| METHODE ELECTRONICS BELGIUM Lontzen | €29.2m | €36.9m |
| ANZIPLAST Izegem | €22.5m | €30.0m |
| GAMMA-WOPLA Mouscron | €37.1m | €41.0m |
| HUBERT DE BACKER Temse | €32.7m | €40.3m |
| ORAC Oostende | €23.1m | €59.6m |
| REMOTEC Deinze | €11.2m | €31.3m |
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 29-06-2026
- Annual accounts 2024filed on 29-08-2025
- Annual accounts 2023filed on 28-06-2024
- Annual accounts 2022filed on 27-07-2023
Acts in the Belgian Official Gazette
- Resignations & appointmentsact of 13-08-2026
- Purpose · Amendment of the articles · Resignations & appointmentsact of 15-02-2024
- Resignations & appointmentsact of 03-02-2023
- Resignations & appointmentsact of 24-01-2023
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about DIDAK INJECTION
- What is the company number of DIDAK INJECTION?
- The company number of DIDAK INJECTION is 0428.125.831. The VAT number is the same number with BE in front: BE 0428.125.831.
- Where is DIDAK INJECTION based?
- The registered office is at Industrieweg 1, 2280 Grobbendonk.Company details
- What does DIDAK INJECTION do?
- According to the KBO register, the main activity is manufacture of rubber and plastic products (NACE 22260).
- What is the legal form of DIDAK INJECTION?
- The legal form of DIDAK INJECTION is Public limited company (NV).
- When was DIDAK INJECTION founded?
- DIDAK INJECTION was founded on 02-01-1986.
- Is DIDAK INJECTION still active?
- Yes, DIDAK INJECTION is an active enterprise in the KBO register.
- How many employees does DIDAK INJECTION have?
- DIDAK INJECTION had an average of 80.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of DIDAK INJECTION?
- The turnover of DIDAK INJECTION was €43.5m in financial year 2025, according to the filed annual accounts.
- Is DIDAK INJECTION profitable?
- In financial year 2025, DIDAK INJECTION made a profit of €2.3m.
- Where can I find the annual accounts of DIDAK INJECTION?
- DIDAK INJECTION filed 40 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
- When are the next annual accounts of DIDAK INJECTION due?
- DIDAK INJECTION must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.